Cargando…

Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)

BACKGROUND: Thyrotropin-secreting pituitary adenomas (TSHomas) are a rare cause of hyperthyroidism. Somatostatin analogs have proved to be effective for inhibiting pituitary hormones secretion, working via interactions with somatostatin receptors (SSTRs). Moreover, antiproliferative activity of soma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Benxia, Zhang, Zhongsheng, Song, Hao, Chi, Yuchun, Shi, Chunling, Xu, Miao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411020/ https://www.ncbi.nlm.nih.gov/pubmed/28434012 http://dx.doi.org/10.12659/MSM.903377

Ejemplares similares

Retracted: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Song, Hao, et al.
Publicado: (2018)

mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer
por: Shahbaz, Muhammad, et al.
Publicado: (2015)

Expression of Somatostatin Receptor Subtypes (SSTR-1–SSTR-5) in Pediatric Hematological and Oncological Disorders
por: Harda, Kristof, et al.
Publicado: (2020)

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020)

Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis
por: War, Sajad A, et al.
Publicado: (2012)

Somatostatin receptors (SSTR1-5) on inhibitory interneurons in the barrel cortex
por: Lukomska, Agnieszka, et al.
Publicado: (2019)

Molecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR)
por: Anzola, Luz Kelly, et al.
Publicado: (2021)

Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands
por: Johnson, Felix, et al.
Publicado: (2023)

Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry
por: Mizutani, Gou, et al.
Publicado: (2012)

Beta cell primary cilia mediate somatostatin responsiveness via SSTR3
por: Adamson, Samantha E., et al.
Publicado: (2023)

Synthesis and preliminary evaluation of octreotate conjugates of bioactive synthetic amatoxins for targeting somatostatin receptor (sstr2) expressing cells
por: Pryyma, Alla, et al.
Publicado: (2021)

Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells
por: Modarai, Shirin R., et al.
Publicado: (2016)

The effect of strength and endurance training on SSTR2 and SSTR5 in patients with colorectal cancer
por: Zanjani, Farhad Safari, et al.
Publicado: (2019)

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
por: Mehta, Shreya, et al.
Publicado: (2015)

ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
por: Vieria Neto, Leonardo, et al.
Publicado: (2013)

Identification of Somatostatin Receptor Subtype 1 (SSTR1) Gene Polymorphism and Their Association with Growth Traits in Hulun Buir Sheep
por: Li, Xue, et al.
Publicado: (2021)

FRI623 Beta Cell Primary Cilia Mediate Somatostatin Responsiveness Via SSTR3
por: Elizabeth Adamson, Samantha, et al.
Publicado: (2023)

A Cyanine‐Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation
por: Heing‐Becker, Isabelle, et al.
Publicado: (2021)

Correction: ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
por: Vieira Neto, Leonardo, et al.
Publicado: (2013)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
por: Behling, Felix, et al.
Publicado: (2018)

Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes
por: Watanabe, Noriko, et al.
Publicado: (2014)

Molecular-Level Understanding of the Somatostatin Receptor 1 (SSTR1)–Ligand Binding: A Structural Biology Study Based on Computational Methods
por: Nagarajan, Santhosh Kumar, et al.
Publicado: (2020)

Tumoral Prostate Shows Different Expression Pattern of Somatostatin Receptor 2 (SSTR2) and Phosphotyrosine Phosphatase SHP-1 (PTPN6) According to Tumor Progression
por: Cariaga-Martinez, Ariel Ernesto, et al.
Publicado: (2009)

Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas
por: Modena, Daniela, et al.
Publicado: (2023)

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
por: Abel, F, et al.
Publicado: (1999)

PSUN346 TSHoma: A Rare Cause of Pituitary Adenoma
por: Malik, Maham, et al.
Publicado: (2022)

MON-467 Expression of Somatostatin Receptors in Aggressive Non-Functioning Pituitary Adenomas
por: Soto, Alfonso, et al.
Publicado: (2019)

Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?
por: Dalm, Simone U., et al.
Publicado: (2017)

Molecular simulations of SSTR2 dynamics and interaction with ligands
por: Gervasoni, Silvia, et al.
Publicado: (2023)

A Rare Case of Thyrotropin Secreting Pituitary Macroadenoma Primarily Treated With Somatostatin Analogue
por: Elsheikh, Arwa Mahmoud, et al.
Publicado: (2021)

Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential
por: Behling, Felix, et al.
Publicado: (2021)

Membrane-displayed somatostatin activates somatostatin receptor subtype-2 heterologously produced in Saccharomyces cerevisiae
por: Hara, Keisuke, et al.
Publicado: (2012)

Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients
por: Grawe, Freba, et al.
Publicado: (2023)

The Value of SSTR2 Receptor-Targeted PET/CT in Proton Irradiation of Grade I Meningioma
por: Pelak, Maciej J., et al.
Publicado: (2021)

The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
por: Zgliczyński, Wojciech, et al.
Publicado: (2013)

Differential between Protein and mRNA Expression of CCR7 and SSTR5 Receptors in Crohn's Disease Patients
por: Taquet, Nathalie, et al.
Publicado: (2009)

Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium
por: Adams, R L, et al.
Publicado: (2005)

Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors
por: Hafez Abdellatif, Ahmed Abdelfattah, et al.
Publicado: (2018)

Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
por: Shamsi, Bilal Haider, et al.
Publicado: (2021)

Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells
por: Kharmate, Geetanjali, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_beg5nd4mne2r2ktr612uq5b0pq